LifeMD, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US53216B1044
USD
3.90
-0.08 (-2.01%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Talkspace, Inc.
Enhabit, Inc.
The Pennant Group, Inc.
Hims & Hers Health, Inc.
Pediatrix Medical Group, Inc.
LifeMD, Inc.
Fulgent Genetics, Inc.
OPKO Health, Inc.
CareMax, Inc.
DocGo, Inc.
Celldex Therapeutics, Inc.

Why is LifeMD, Inc. ?

1
The company has declared Positive results for the last 4 consecutive quarters
  • NET PROFIT(HY) Higher at USD -4.73 MM
  • DEBT-EQUITY RATIO (HY) Lowest at -1,313.26 %
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of -36.39%, its profits have risen by 91.8%
3
High Institutional Holdings at 57.97%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
4
Underperformed the market in the last 1 year
  • Even though the market (S&P 500) has generated returns of 13.68% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -36.39% returns
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to LifeMD, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is LifeMD, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
LifeMD, Inc.
-36.07%
-0.50
97.97%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
54.85%
EBIT Growth (5y)
15.17%
EBIT to Interest (avg)
-23.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
6.65
Sales to Capital Employed (avg)
27.08
Tax Ratio
4.12%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
57.97%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
160.95
EV to EBIT
188.43
EV to EBITDA
16.10
EV to Capital Employed
-8.64
EV to Sales
0.75
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-138.42%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
NET PROFIT(HY)

Higher at USD -4.73 MM

DEBT-EQUITY RATIO (HY)

Lowest at -1,313.26 %

-6What is not working for the Company
PRE-TAX PROFIT(Q)

At USD -2.23 MM has Fallen at -98.65%

NET PROFIT(Q)

At USD -2.65 MM has Fallen at -78.84%

Here's what is working for LifeMD, Inc.

Debt-Equity Ratio
Lowest at -1,313.26 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Depreciation
Highest at USD 2.99 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for LifeMD, Inc.

Pre-Tax Profit
At USD -2.23 MM has Fallen at -98.65%
over average net sales of the previous four periods of USD -1.12 MM
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -2.65 MM has Fallen at -78.84%
over average net sales of the previous four periods of USD -1.48 MM
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (USD MM)